Toronto - Free Realtime Quote CAD

CareRx Corporation (CRRX.TO)

3.2300 +0.0300 (+0.94%)
As of 9:30:00 AM EDT. Market Open.
Dividend
CRRX.TO announced a cash dividend of CAD 0.022 with an ex-date of Sep. 15, 2026
Chart Range Bar
Loading chart for CRRX.TO
  • Previous Close 3.2000
  • Open 3.2300
  • Bid 3.2200 x --
  • Ask 3.2200 x --
  • Day's Range 3.2300 - 3.2300
  • 52 Week Range 2.9300 - 4.0000
  • Volume 201
  • Avg. Volume 23,065
  • Market Cap (intraday) 204.934M
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) 7.69
  • EPS (TTM) 0.4200
  • Earnings Date (est.) Nov 2, 2026
  • Forward Dividend & Yield 0.09 (2.75%)
  • Ex-Dividend Date Sep 15, 2026
  • 1y Target Est 5.14

CareRx Corporation, together with its subsidiaries, provides pharmacy services to senior homes and other congregate care settings in Canada. The company also offers medication management services. It serves long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is based in Toronto, Canada.

www.carerx.ca

1,433

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview

Trailing total returns as of 8/27/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

CRRX.TO
14.24%
S&P/TSX Composite index (^GSPTSE)
15.03%

1-Year Return

CRRX.TO
10.10%
S&P/TSX Composite index (^GSPTSE)
28.92%

3-Year Return

CRRX.TO
72.03%
S&P/TSX Composite index (^GSPTSE)
84.80%

5-Year Return

CRRX.TO
47.98%
S&P/TSX Composite index (^GSPTSE)
77.56%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized
 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 93.57M
Earnings 363k
Profit Margin 0.39%

Q4

FY25

Q1

FY26

Q2

FY26

0
20M
40M
60M
80M
5.0%
10.0%
15.0%
20.0%
 

Analyst Insights

View More

Analyst Price Targets

4.25
5.14 Average
3.2300 Current
6.25 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Statistics

View More

Valuation Measures

Annual
As of 8/25/2026
  • Market Cap

    205.57M

  • Enterprise Value

    272.33M

  • Trailing P/E

    7.71

  • Forward P/E

    35.97

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.56

  • Price/Book (mrq)

    1.88

  • Enterprise Value/Revenue

    0.72

  • Enterprise Value/EBITDA

    9.30

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.13%

  • Return on Assets (ttm)

    3.34%

  • Return on Equity (ttm)

    27.34%

  • Revenue (ttm)

    376.8M

  • Net Income Avi to Common (ttm)

    26.87M

  • Diluted EPS (ttm)

    0.4200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.57M

  • Total Debt/Equity (mrq)

    69.65%

  • Levered Free Cash Flow (ttm)

    16.52M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch